Header Logo

Connection

CURTIS A PETTAWAY to Cetuximab

Back to Details
This is a "connection" page, showing publications CURTIS A PETTAWAY has written about Cetuximab.
CURTIS A PETTAWAY
Connection Strength
0.012
Cetuximab
  1. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Clin Cancer Res. 2002 May; 8(5):1253-64.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.